IIC
ALZN icon

Integrated Investment Consultants’s Alzamend Neuro ALZN Stock Holding History

Integrated Investment Consultants’s Portfolio ALZN Stock Details ALZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-30
Closed -$9.48K – 235
2023
Q3 		$9.48K Hold
30
– – ﹤0.01% 225
2023
Q2 		$20.4K Buy
+30
New +$23.5K 0.01% 265

Other funds holding ALZN

Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
RA
RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HIA
Harbor Investment Advisory Lutherville, Maryland $1.43B AUM 30.71% 1-Year Est. Return

Integrated Investment Consultants's ALZN Position: Q4 2023 in Review

Integrated Investment Consultants sold out of Alzamend Neuro (ALZN) in Q4 2023, closing a stake of 30 shares — an estimated $9.48K sold.

Integrated Investment Consultants first reported a position in ALZN in Q2 2023 and held it in 2 quarters. The position peaked at $20.4K in Q2 2023. 14 funds tracked by Wall St. Rank hold ALZN as of Q4 2023.

  • Integrated Investment Consultants reported no remaining Alzamend Neuro position as of Q4 2023 after selling out during the quarter.
  • Integrated Investment Consultants sold 30 Alzamend Neuro shares in Q4 2023, an estimated $9.48K.
  • Integrated Investment Consultants first reported a position in Alzamend Neuro in Q2 2023 and held it in 2 quarters.
  • Integrated Investment Consultants's Alzamend Neuro position peaked at $20.4K in Q2 2023.
  • 14 funds tracked by Wall St. Rank held Alzamend Neuro as of Q4 2023.

Based on Integrated Investment Consultants's 13F filing for Q4 2023, filed 23 Jan 2024.